Back
BridgeBio Pharma Stock Price Chart
Sponsored
BBIO
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
44
BBIO
BridgeBio Pharma
Last Price:
26.72
Seasonality Move:
21.04%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBIO is experiencing slight buying pressure.
BridgeBio Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.7 | Buy |
20-day SMA: | 27.46 | Sell |
50-day SMA: | 26.49 | Buy |
200-day SMA: | 30 | Sell |
8-day EMA: | 26.98 | Sell |
20-day EMA: | 27.11 | Sell |
50-day EMA: | 26.8 | Sell |
200-day EMA: | 27.46 | Sell |
BridgeBio Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.14 | Buy |
Relative Strength Index (14 RSI): | 48.62 | Sell |
Chaikin Money Flow: | 489817 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.88 - 29.12) | Sell |
Bollinger Bands (100): | (25.1 - 28.78) | Sell |
BridgeBio Pharma Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BridgeBio Pharma Stock
Is BridgeBio Pharma Stock a Buy?
- BridgeBio Pharma share price is 26.73 while BBIO 8-day simple moving average is 26.70, which is a Buy signal.
- The stock price of BBIO is 26.73 while BridgeBio Pharma 20-day SMA is 27.46, which makes it a Sell.
- BridgeBio Pharma 50-day simple moving average is 26.49 while BBIO share price is 26.73, making it a Buy technically.
- BBIO stock price is 26.73 and BridgeBio Pharma 200-day simple moving average is 30.00, creating a Sell signal.
BBIO Technical Analysis vs Fundamental Analysis
Sell
44
BridgeBio Pharma (BBIO)
is a Sell
Is BridgeBio Pharma a Buy or a Sell?
-
BridgeBio Pharma stock is rated a Sell
The current BridgeBio Pharma [BBIO] share price is $26.73. The Score for BBIO is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
BridgeBio Pharma Stock Info
Market Cap:
5.03B
Price in USD:
26.73
Share Volume:
1.54M
BridgeBio Pharma 52-Week Range
52-Week High:
44.32
52-Week Low:
21.62
Sell
44
BridgeBio Pharma (BBIO)
is a Sell
BridgeBio Pharma Share Price Forecast
-
What is the BridgeBio Pharma stock price today?
The BridgeBio Pharma stock price is 26.73 USD today. -
Will BBIO stock go up or go down?
BridgeBio Pharma> share price is forecast to RISE/FALL based on technical indicators -
Is BridgeBio Pharma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, BridgeBio Pharma is overvalued.
Is BridgeBio Pharma Stock a Buy?
- BridgeBio Pharma share price is 26.73 while BBIO 8-day exponential moving average is 26.98, which is a Sell signal.
- The stock price of BBIO is 26.73 while BridgeBio Pharma 20-day EMA is 27.11, which makes it a Sell.
- BridgeBio Pharma 50-day exponential moving average is 26.80 while BBIO share price is 26.73, making it a Sell technically.
- BBIO stock price is 26.73 and BridgeBio Pharma 200-day simple moving average is 27.46, creating a Sell signal.
Fundamental Analysis of BridgeBio Pharma
Is BridgeBio Pharma a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.01 per share, an increase this year of $1.24 per share, and a decrease next year of $1.28 per share.
Technical Analysis of BridgeBio Pharma
Should I short BridgeBio Pharma stock?
- BBIO Moving Average Covergence Divergence (MACD) indicator is 0.14, suggesting BridgeBio Pharma is a Buy
- BridgeBio Pharma Relative Strength Index (RSI) is 48.62, which suggest BridgeBio Pharma is oversold
- The Bollinger Bands (25) for BridgeBio Pharma is (24.88 - 29.12), which suggest BridgeBio Pharma is a Sell
- The Bollinger Bands (100) for BridgeBio Pharma is (25.1 - 28.78), which suggest BridgeBio Pharma is a Sell
* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.